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Abstract
Immunodeficient mouse–human chimeras provide a powerful approach to study host spe-
cific pathogens like Plasmodium (P.) falciparum that causes human malaria. Existing
mouse models of P. falciparum infection require repeated injections of human red blood
cells (RBCs). In addition, clodronate lipsomes and anti-neutrophil antibodies are injected to
suppress the clearance of human RBCs by the residual immune system of the immunode-
ficient mice. Engraftment of NOD-scid Il2rg-/- mice with human hematopoietic stem cells
leads to reconstitution of human immune cells. Although human B cell reconstitution is
robust and T cell reconstitution is reasonable in the recipient mice, human RBC reconstitu-
tion is generally poor or undetectable. The poor reconstitution is mainly the result of a
deficiency of appropriate human cytokines that are necessary for the development and
maintenance of these cell lineages. Delivery of plasmid DNA encoding human erythropoie-
tin and interleukin-3 into humanized mice by hydrodynamic tail-vein injection resulted in sig-
nificantly enhanced reconstitution of erythrocytes. With this improved humanized mouse,
here we show that P. falciparum infects de novo generated human RBCs, develops into
schizonts and causes successive reinvasion. We also show that different parasite strains
exhibit variation in their ability to infect these humanized mice. Parasites could be detected
by nested PCR in the blood samples of humanized mice infected with P. falciparum K1 and
HB3 strains for 3 cycles, whereas in other strains such as 3D7, DD2, 7G8, FCR3 and
W2mef parasites could only be detected for 1 cycle. In vivo adaptation of K1 strain further
improves the infection efficiency and parasites can be detected by microscopy for 3 cycles.
The parasitemia ranges between 0.13 and 0.25% at the first cycle of infection, falls between
0.08 and 0.15% at the second cycle, and drops to barely detectable levels at the third cycle
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of infection. Compared to existing mouse models, our model generates human RBCs de
novo and does not require the treatment of mice with immunomodulators.
Introduction
Malaria is caused by parasites of the Plasmodium species which are transmitted by infected
Anopheles mosquitoes. Plasmodium species are host specific, making it difficult to model
human parasite infection in laboratory animals. Therefore, most in vivo experimental studies
have been carried out with mouse and rodent Plasmodium strains. However, differences in
invasion and disease pathology between parasite species remain a major problem. The lack of
appropriate experimental models have hampered the evaluation of new drugs and vaccines
prior to clinical trials [1].
One approach to overcome this challenge is to supplement severe combined immunode-
ficient (scid) mice with human RBCs. The resulting mice support a limited blood stage P. fal-
ciparum infection [2–6]. The requirements to inject large volumes of human RBCs repeatedly
along with treating mice with anti-neutrophil antibody and clodronate liposomes to suppress
the rapid clearance of the injected human RBCs by macrophages makes this a difficult system
to work with [7]. NOD-scid Il2rg-/- or NSG mice developed recently bears a targeted mutation
at the interleukin-2 receptor (IL-2R) gamma chain locus. Macrophages are functionally imma-
ture in NSG mice due to IL2-R gamma chain deficiency [8]. P. falciparum infection was also
reported in NSG mice without the use of clodronate liposomes or anti-neutrophil antibody,
but still requiring daily human RBC injection [9]. The best small animal model for malaria
infection so far is the human RBC-supplemented, immune cell-optimized humanized (or
RICH) mice that support multiple cycles of P. falciparum infection in the presence of a human
immune system [10]. Nevertheless, it is still a formidable challenge to establish a malaria infec-
tion model that does not require regular human RBC supplementation.
NSG mice have been reported to support an increased efficiency of human cell engraftment,
including hematopoeitic stem cells (HSCs) [8, 11]. However, very few human RBCs are gener-
ated in the recipient mice following engraftment of human HSCs [12]. Expressing human cyto-
kines interleukin (IL)-3 and erythropoietin (EPO) in NSG recipient mice leads to an improved
reconstitution of human RBCs [13]. Using these improved humanized mice, we show here that
P. falciparum can cause multiple cycles of infection without any myelodepletion and without
human RBC supplementation.
Results
P. falciparum can infect and multiply in human RBCs generated in mice
Mice with>40% of human leukocyte reconstitution were injected with plasmids encoding
human IL-3 and EPO. One month later mice were analysed for human RBC reconstitution.
The human RBC reconstitution in mice used in this study ranged between 1.6 and 4.0% (S1
Table). Interestingly reticulocytes account for 10 to 30% of human RBCs as measured by stain-
ing the blood cells with anti-glycophorin antibodies and thiozol orange (S1 Fig). 100 μl of
whole blood from these mice were used for ex vivo infection with 1x106 mature P. falciparum
schizonts (3D7 strain). Microscopic analysis of blood smears at 16 h showed ring stage infec-
tion (S2A Fig) with a parasitemia of 0.02 to 1.6% (or 1 to 59.3% when normalised to human
RBC frequency in the whole blood). Different batches of mice as well as stem cells from differ-
ent sources were used for each batch. The following factors may be related to the high variation
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in parasitemia (S1 Table), i.e. genetic background of the donor, the quality of the hematopoi-
etic stem cells, the efficiency of the hydrodynamic injection and therefore the IL-3/EPO expres-
sion. The ex vivo culture was maintained for multiple cycles and different stages of parasite
development, including early ring, late ring, trophozoites, and schizonts, were observed over
time (S2B–S2F Fig). Viable merozoites were produced as indicated by reinvasion of new RBCs
at 64 h after the culture was initiated (S2G Fig). In contrast, blood from control NSG mice
(recipient mice without any human hematopoietic stem cells engraftment) did not show any
infection.
In order to confirm that the infected RBCs are in fact from humanized mouse origin and
not from contaminant RBCs carried along with purified schizonts, we performed a double
staining experiment. RBCs from humanized mice and in vitro parasite culture (source of schiz-
onts) were stained with CellTracker Red CMTPX and Green CMFDA (Life Technologies) fluo-
rescent dyes, respectively. These dyes freely pass through cell membranes into the cells, where
they transform into a cell-impermeable, fluorescent product which are retained for several
days. After overnight culture of the purified schizonts with blood from humanized mice, the
parasites were stained with DAPI and imaged under fluorescent microscope. The parasites
(blue) were observed in RBCs stained with red confirming that the parasites invaded only the
de novo generated human RBC from mice (Fig 1).
A previous study has shown that the P. falciparum 7G8 and Camp strains can invade mouse
erythrocytes but development was blocked at the early ring stage, leading to the lysis of the
Fig 1. Infection of P. falciparum (3D7) in de novo generated human RBCs.RBCs from humanized mice and purified schizonts were stained with Red
CMTPX and Green CMFDA dyes, respectively. After the overnight culture, the parasites were stained with DAPI and imaged under fluorescent microscope
(Panel A). Panel B and C represent the images taken under Green (contaminant RBC from culture) and Red (humanized mice RBC) channels. A ring stage
parasite can be seen in red stained RBC (Panel C) indicating the infection of de novo generated human RBC in humanized mice. Panel D and E represent
the bright field and composite images respectively.
doi:10.1371/journal.pone.0129825.g001
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infected RBCs [14]. In our study, multiple rounds of infection were observed with 3D7 strain
in blood from humanized mice but not from NSG mice, suggesting that the infected cells are
human RBCs only. Furthermore, the infected RBCs were stained positive for human glyco-
phorin a/b (S3 Fig). These results show that P. falciparum can infect, develop and mature in
the de novo generated human RBCs in mice.
To test whether de novo generated human RBCs can be directly infected in vivo, humanized
mice were injected with 2x107 purified schizonts (3D7) intravenously. The amount of injected
schizonts was calculated based on the ex vivo infection using 1x106 schizonts in 100 μl blood
from humanized mice and approximately 2 ml blood per mouse. However, no in vivo infection
was detected in the circulation by microscopy, flow cytometry or nested PCR. The nested PCR
amplifies the conserved sequences of the small-subunit rRNA (ssrRNA) gene [15] and would
allow us to detect very low levels of circulating parasites. This lack of infection could be due to
the fact that P. falciparum schizonts-infected RBCs are more rigid than the ring stage parasite-
infected RBCs [16, 17], and therefore are more likely to be retained in the spleen before they
rupture and release the merozoites that can invade new RBCs. Therefore, we injected human-
ized mice with ring stage parasites obtained from ex vivo infection of whole blood from
humanized mice. The maximal parasitemia in the ex vivo cultures was 1.6% (among total
RBCs) and therefore the number of injected ring stage parasites in 100 μl was about 8x106
[0.016 x 5x108 (total RBC in 100 μl mouse blood)]. Parasites were detected by nested PCR at 48
h post infection (Fig 2). Because nuclear materials from killed parasites are rapidly cleared
from the circulation and do not contribute significantly to PCR amplification [18], the result
indicate P. falciparum infection in humanized mice but at low efficiency.
Different strains of P. falciparum show variation in their ability to infect
RBCs from humanized mice
To identify a parasite strain that can infect humanized mice more efficiently, we screened vari-
ous P. falciparum strains along with a knob-less clone of 3D7 (3D7KL) and KAHRP k/o para-
sites [19]. Ring stage parasites were prepared from ex vivo culture with 100 μl blood from
humanized mice as described above. The level of parasitemia was considered low but detectable
when at least 1 parasite could be detected in 100 microscopic fields. Humanized mice were
Fig 2. Detection of P. falciparum (3D7) infection in humanized mice by nested PCR.Humanized mice were injected intravenously with either live ring
stage parasites (M1, M2 and M3) or killed ring stage parasites (M4, M5 and M6). 20 μl blood samples were collected immediately after injection or 48, 96 and
144 h after injection and the presence of parasite DNA was assayed by nested PCR. Arrow indicates 205 bp PCR product. Genomic DNA prepared from
blood of an uninfected mouse was used as negative (-ve) control.
doi:10.1371/journal.pone.0129825.g002
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injected intravenously with the culture containing the ring stage parasites and infection was
analyzed at 48, 96 and 144 h after injection. Among the 9 strains tested, parasite PCR products
for FCR3 and T994 strains were detected in blood samples taken immediately after injection
but not after 48 h. Parasite PCR products for DD2, KAHRP k/o, 7G8, and W2mef strains were
detected at 48 h after injection. Parasite PCR products for HB3, K1 and 3D7KL strains were
detected at 96 h after injection. At 144 h after injection, parasite PCR products were detected in
one of the two K1 and HB3 samples (Fig 3 and S4 Fig), suggesting that these parasites can
infect humanized mice for three cycles.
P. falciparum K1 SMG01 infection in humanized mice can be detected
by microscopy for multiple cycles
To further increase efficiency of infection, i.e., detectable by microscopy, K1 strain was selected
by in vivo adaptation in NSG mice supplemented with human RBCs. Human RBC-supple-
mented NSG mice infected with 2x107 ring stage parasites showed 2% parasitemia 48 h after
injection. Afterwards, however, parasitemia declined to undetectable level. After 16 days, para-
sitemia was detected again by microscopy and reached 2% by day 20. The details of experimen-
tal procedures of in vivo adaptation are shown in S5 Fig. Using the adapted K1 strain (named
SMG01) to infect new human RBC-supplemented NSG mice, parasitemia was consistently
detected for over 10 days (S6 Fig).
We then examined whether SMG01 parasites can generate microscopy-detectable infection
in humanized mice where human RBCs are generated de novo. Unlike the parental K1 strain,
SMG01 ring stage parasites were detected for three cycles by Giemsa staining of blood smear
(Fig 4A–4C). The parasitemia ranged between 0.13 and 0.25% at the first cycle of infection, fell
between 0.08 and 0.15% at the second cycle, and dropped to barely detectable levels at the third
cycle of infection (Fig 4D). The parasitemia (%) versus human RBC percentage (huRBC%) is
shown in Fig 4E, where the parasitemia/huRBC% (i.e., the parasitemia with respect to human
Fig 3. Infection of ex vivo cultured P. falciparumK1 strain in humanized mice.Humanized mice were infected with ex vivo cultured P. falciparum K1 ring
stage parasites and the parasite PCR product (indicated by arrow) was determined using nested PCR at the indicated time points after parasite injection. 3
out of 4 mice (M1, M3 and M4) showed infected human RBCs until the 3rd cycle. Genomic DNA prepared from blood of an uninfected mouse was used as
negative (-ve) control.
doi:10.1371/journal.pone.0129825.g003
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Fig 4. Direct infection of humanized mice by selected P. falciparum SMG01.Humanized mice were injected intravenously with the ring stage parasites
of the in vivo adapted K1 P. falciparum strain SMG01. Thin blood smear was made and stained with Giemsa. Representative ring stage parasites are shown
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RBCs) is 10.3% ± 2.4%. The low level of parasitemia could be attributed to the fact that there
were only 1.5 to 2.8% human RBCs in the circulation. As a result, short-lived free merozoites
are probably cleared before they have a chance to invade another human RBC to sustain the
infection. Nevertheless, these results show that human RBCs generated de novo in mice can be
infected by a selected P. falciparum K1 SMG01 parasite for at least 3 cycles.
Discussion
In both human RBC-supplemented NSG mice and the humanized mice presented here, some
strains of P. falciparum are able to induce significant levels of infection. In the in vivo adapta-
tion process, initial parasite clearance and reappearance after a period of time is observed.
These results are in agreement with a previous report [20] and this may be due to the retention
of majority of the infected RBCs in the sinus cord of the spleen [21, 22]. Failure to detect newly
invaded parasites after injection of schizonts could also be due to the reason that infected RBCs
are retained in the spleen due to their increased rigidity. Studies have shown that the deform-
ability of infected RBCs is a key factor affecting their clearance. Because infected RBCs become
more rigid as the development of the parasite progresses [16, 17], they are likely being cleared
more rapidly [22]. Screening parasite strains and their further adaptation in mice may select
for parasites that maintain higher deformability of the infected RBCs, although rigorous and
systematic experiments are needed to confirm this possibility. The in vivo adaptation of the
parasite we used is similar to Angulo-Barturen et al [20]. However we showed infection in de
novo generated huRBCs in a humanized mouse model. More recently Arnold et al [23]
reported a NSG-IV model of malaria parasite infection, which does not require preadaptation
of the parasites. However, these mice still required injection of clodronate liposomes along
with human blood.
All existing mouse models of P. falciparum infection rely on supplementing immunode-
ficient mice with human RBCs and/or the treatment with clodronate liposomes. In compari-
son, the humanized mouse model used in this study generates de novo human RBCs as well as
human immune cells from the same donor. For the first time the humanized mouse model
presented here allows successful infection of P. falciparum in vivo without any human RBC
supplementation or treating mice with anti-neutrophil antibodies and clodronate liposomes
to suppress clearance of human RBCs. The amount of de novo generated huRBCs is neverthe-
less still fairly low. Further improvement of human RBC reconstitution in our model is neces-
sary in order to sustain in vivo parasite infection for more than three cycles and significantly
increase parasitemia levels. This model, after further development, has the potential to serve as
a fully integrated humanized mouse model for studying host immune responses against P. fal-




NSG mice were purchased from the Jackson Laboratories (Bar Harbor, Maine) and maintained
under specific pathogen-free conditions in the animal facilities at National University of Singa-
pore, Singapore. Reconstitution of human blood lineage cells was carried out as described
at 48 h (A), 96 h (B) and 144 h (C) after infection. Quantification of parasitemia is presented in (D). Positive (+ve) reading means that the level of parasitemia
was low but detectable when at least 1 parasite could be detected in 100 microscopic fields. The parasitemia versus human RBC percentage (huRBC%) is
shown in (E), where the average parasitemia/huRBC% is 10.3% ± 2.4%.
doi:10.1371/journal.pone.0129825.g004
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previously [13]. Briefly, newborn NSG pups (less than 48 h old) were irradiated with 100 cGy
using a Gamma radiation source and injected intracardially with CD34+ HSCs from cord
blood (1x105 cells/recipient). Mice were analyzed for human leukocyte reconstitution at 10–12
weeks of age. Mice with 40% or more human leukocyte reconstitution in the peripheral blood
mononuclear cells (PBMCs) were injected hydrodynamically with plasmids encoding human
IL-3 and EPO to improve human RBC reconstitution, as specified in detail in [13]. The level of
human RBCs in humanized mice was quantified by staining blood cells with FITC-conjugated
anti-human glycophorin a/b antibody (BioLegend, USA). Representative FACS data for
human RBC characterization is presented in S1 Fig. Mice with a minimum of 1.5% human
RBC reconstitution were then used for subsequent experimentation. All studies involving
human HSC from cord blood and mice were approved by the institutional review board (IRB)
and institutional animal care and use committee (IACUC) of the National University of Singa-
pore. Studies involving mice were also approved by the committee on animal care (CAC) of
the Massachusetts Institute of Technology.
P. falciparum culture
P. falciparum strains 3D7, DD2, HB3, K1, KAHRP k/o, 7G8, FCR3, T994 and W2Mef were
obtained fromMalaria Research and Reference Reagent Resource (MR4) and maintained in
leukocyte-free human erythrocytes as described by Trager and Jensen [24]. P. falciparum
3D7KL (knob-less) clone was generated by limiting dilution and selecting for knob-less clone.
This clone does not produce knobs on the infected erythrocyte membrane and has increased
deformability compared to the parental line (Li Ang, personal communication). The parasites
were treated with trypsin/chymotrypsin or neuraminidase depending on the strain for one h at
37°C with shaking before purification of schizonts in order to prevent the reinvasion of residual
RBCs [25]. The late stage schizonts were purified by percoll gradient centrifugation according
to Fernandez [26].
Ex vivo infection
100 μl whole blood was collected via facial vein from humanized mice and washed twice with
RPMI medium. RBCs were resuspended in 1 ml PRMI medium containing 0.5% heat-inacti-
vated human serum. After addition of 1x106 purified schizonts the mixture was incubated at
37° C for 16 to 64 hrs and then analyzed for infection by Giemsa staining of blood smear.
Fluorescent staining of RBCs
Whole blood collected from humanized mice via facial vein bleeding was washed with RPMI
and incubated with 10 μMCellTracker Red CMTPX dye (Life Technologies) for 30 minutes at
37°C under shaking condition. Similarly, the in vitro P. falciparum culture was also stained
with CellTracker Green CMFDA dye. The humanized mouse RBCs and the P. falciparum cul-
ture were washed with RPMI and the schizonts were purified. After co-culture of schizonts
with blood from humanized mice overnight, the parasites were stained with DAPI and imaged
under fluorescent microscope.
RBC supplementation and adaptation of parasites
For RBC supplementation, human blood was pelleted and resuspended in equal volume of
RPMI medium containing 50% heat-inactivated human serum (Invitrogen). 4 to 6 weeks old
male or female NSG mice were each injected daily with 1 ml human RBCs intraperitoneally.
When human RBCs reached ~20% as determined by anti-glycophorin a/b staining (after about
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7–10 days), mice were used for in vivo adaptation of parasites as described by Angulo-Barturen
et al [20]. To infect RBC-supplemented NSG mice, P. falciparum K1 strain of the parasite was
cultured with human RBCs as described [24]. At the peak of ring stage infection, the culture
was harvested and 2x107 ring stage parasites were injected intravenously per recipient mice.
Infection of humanized mice
Parasite infection of humanized mice was carried out in three ways. In the first approach, puri-
fied schizonts were injected into humanized mice intravenously (2x107 schizonts per mouse).
In the second approach, 100 μl whole blood from humanized mice containing human RBCs
was infected with 1x106 schizonts overnight. The parasitemia in these infected cultures ranged
between 0.02 and 1.6% (correspond to 2x104 to 8x106 parasites in total). The cultures were
washed with incomplete RPMI media and then injected intravenously into the same mouse
from which the blood was collected. In the third approach, the selected parasite K1 strain was
used to infect human RBC-supplemented NSG mice as above. When parasitemia reached ~2%,
the blood was harvested, treated with tryspin/chymotrypsin and 2x107 ring stage parasites
were injected intravenously into humanized mice directly or from a frozen stock of K1 adapted
parasite strain.
Parasite detection by nested PCR and immunofluorescence assay (IFA)
Parasite genomic DNA was extracted using the Easy-DNA Kit (Invitrogen) following the man-
ufacturer’s protocol. Nested PCR was performed as described by Snounou et al [15]. Genomic
DNA prepared from blood of uninfected mice was used as negative control in all PCR reac-
tions. IFA was carried out as described by Blackman [27].
Supporting Information
S1 Fig. Reticulocytes among total human RBCs in humanized mice. The top panel shows
representative percentage of human RBCs in 4 different mice. The bottom panel shows the
reticulocytes among human RBCs in the same mice. RBCs are enucleated and the RNA slowly
degrades as the cells mature. However reticulocytes (young RBCs) carry residual RNAs which
can be stained with Thiozol Orange (TO). Since leukocytes are removed from the samples only
reticulocytes will be stained. To differentiate human reticulocytes they are co-stained with anti
glycophorin a/b (GPA/B) antibodies.
(PDF)
S2 Fig. Ex vivo infection of human RBCs from humanized mice by P. falciparum (3D7).
Parasites and whole blood from humanized mice were mixed and co-cultured. A thin smear of
the culture was stained with Giemsa at different time points and visualized for infected RBCs.
A) Representative image of Giemsa staining at 16 h after starting the culture showing two
infected RBCs with ring stage parasites. B-G) Giemsa stained parasites showing different devel-
opmental stages: purified schizonts from in vitro culture (B), newly invaded early ring stage at
16 h (C), late ring at 24 h (D), trophozoite stage at 32 h (E), schizont stage at 48 h (F), and ring
stage parasite 64 h after reinvasion of new uninfected RBCs (G). Representative data from 6
mice are shown.
(PDF)
S3 Fig. P. falciparum infects only human RBCs from humanized mice blood.Whole blood
from humanized mice were cultured with 3D7 parasites and thin smear of the culture was
stained with anti-human glycophorin a/b antibody and DAPI to stain the parasites. Shown are
representative images of DAPI (parasite) stain (A), anti-human glycophorin a/b stain (B), and
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merged image (C). (D) is overexposure of (B) to visualize both human and mouse RBCs.
(PDF)
S4 Fig. Infection of humanized mice with different P. falciparum strains. P. falciparum
strains DD2, HB3, K1 (A), KAHRP k/o, 7G8, FCR3 (B), T994, W2Mef and 3D7KL (C) were
used to infect humanized mice and the parasite PCR products with 205 bp size (indicated by
arrow) were detected by nested PCR at the indicated time points after parasite infection. Para-
site PCR products were detected in one of the two K1 and HB3 samples at 3rd infection cycle
whereas in other strains infected RBCs can only be detected until the 1st cycle of blood stage
infection. The last lane represents negative (-ve) control for which genomic DNA prepared
from blood was used as template.
(PDF)
S5 Fig. In vivo adaptation of P. falciparum K1 strain in NSG mice supplemented with
human RBCs. NSG mice (M1 and M2) are supplemented daily with human RBCs by intraper-
itoneal injection. Antibodies to glycophorin a/b (conjugated to FITC) was used to stain the
human RBCs for quantification. When human RBC reconstitution reaches about 20% (on day
9 as shown above), NSG mice were infected with 2x107 ring stage parasites of P. falciparum K1
strain. The supplementation of human RBCs was continued throughout the experiment and an
increase in human RBC reconstitution up to 89% could be seen in M1 on day 28. 48h after
infection with the parasite, a parasitemia level of 2% was detected. Later on parasitemia, how-
ever, decreased to undetectable levels. 16 days after infection parasitemia became detectable by
microscopy again and reached 2% by day 20. This adapted P. falciparum K1 strain named
SMG01 was used for further studies.
(PDF)
S6 Fig. Infection of human RBC supplemented NSGmice with adapted P. falciparum K1
parasite strain SMG01. The selected and in vivo adapted parasite strain SMG01 can be
detected consistently in human RBC-supplemented NSG mice.
(PDF)
S1 Table. Ex vivo infection of human RBCs from humanized mice by P. falciparum (3D7).
Total human RBCs and parasitemia in 14 mice are shown. Parasitemia ranged between 0.02%
(mouse 4) and 1.6% (mouse 6) or 1% to 59.3% when normalized to human RBCs.
(PDF)
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